Skip to main content
medRxiv
  • Home
  • About
  • Submit
  • ALERTS / RSS
Advanced Search

Health and Economic Effects of COVID-19 control in Australia: Modelling and quantifying the payoffs of ‘hard’ versus ‘soft’ lockdown

View ORCID ProfileR. Quentin Grafton, John Parslow, View ORCID ProfileTom Kompas, View ORCID ProfileKathryn Glass, View ORCID ProfileEmily Banks, View ORCID ProfileKamalini Lokuge
doi: https://doi.org/10.1101/2020.08.31.20185587
R. Quentin Grafton
1Australian National University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for R. Quentin Grafton
  • For correspondence: Quentin.Grafton@anu.edu.au
John Parslow
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Tom Kompas
2University of Melbourne
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Tom Kompas
Kathryn Glass
1Australian National University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kathryn Glass
Emily Banks
1Australian National University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Emily Banks
Kamalini Lokuge
1Australian National University
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • ORCID record for Kamalini Lokuge
  • Abstract
  • Full Text
  • Info/History
  • Metrics
  • Data/Code
  • Preview PDF
Loading

Abstract

Objective(s) Australia requires high quality evidence to optimise likely health and economy outcomes to effectively manage the current resurgence of COVID-19. We hypothesise that the most stringent social distancing (SD) measures (100% of level in Australia in April 2020) deliver better public health and economy outcomes.

Design ‘Fit-for-purpose’ (individual-based and compartment) models were used to simulate the effects of different SD and detection strategies on Australian COVID-19 infections and the economy from March to July 2020. Public reported COVID-19 data were used to estimate model parameters.

Main outcome measures Public health and economy outcomes for multiple social distancing levels were evaluated, assessing “hard” versus “soft” lockdowns, and for early versus later relaxation of social distancing. Outcomes included costs and the timing and magnitude of observed COVID-19 cases and cumulative deaths in Australia from March to June 2020.

Results Higher levels of social distancing achieve zero community transmission with 100% probability and lower economy cost while low levels of social distancing result in uncontrolled outbreaks and higher economy costs. High social distancing total economy costs were $17.4B versus $41.2B for 0.7 social distancing. Early relaxation of suppression results in worse public health outcomes and higher economy costs.

Conclusion(s) Better public health outcomes (reduced COVID-19 fatalities) are positively associated with lower economy costs and higher levels of social distancing; achieving zero community transmission lowers both public health and economy costs compared to allowing community transmission to continue; and early relaxation of social distancing increases both public health and economy costs.

Significance The known is that COVID-19 infections can be suppressed with social distancing (SD) measures of sufficient stringency and duration.

The new is we find highest levels of SD (100% SD that prevailed in April 2020) generate much lower COVID-9 deaths; reduced SD days; increased economic activity; and much higher probability of elimination over a subsequent 12-month period than lower levels of SD.

The implications are that greater levels of SD are preferred to lower SD because they deliver both better public health and lower economy costs.

Competing Interest Statement

The authors have declared no competing interest.

Funding Statement

No funding to report.

Author Declarations

I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.

Yes

The details of the IRB/oversight body that provided approval or exemption for the research described are given below:

No IRB and/or ethics approval is required.

All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.

Yes

I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).

Yes

I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.

Yes

Footnotes

  • jsparslow{at}gmail.com, Tom.Kompas{at}unimelb.edu.au, Kathryn.Glass{at}anu.edu.au, Emily.Banks{at}anu.edu.au, Kamalini.Lokuge{at}anu.edu.au

Data Availability

All relevant data is contained in the paper and the technical appendix.

Copyright 
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. It is made available under a CC-BY-NC-ND 4.0 International license.
Back to top
PreviousNext
Posted September 02, 2020.
Download PDF
Data/Code
Email

Thank you for your interest in spreading the word about medRxiv.

NOTE: Your email address is requested solely to identify you as the sender of this article.

Enter multiple addresses on separate lines or separate them with commas.
Health and Economic Effects of COVID-19 control in Australia: Modelling and quantifying the payoffs of ‘hard’ versus ‘soft’ lockdown
(Your Name) has forwarded a page to you from medRxiv
(Your Name) thought you would like to see this page from the medRxiv website.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Share
Health and Economic Effects of COVID-19 control in Australia: Modelling and quantifying the payoffs of ‘hard’ versus ‘soft’ lockdown
R. Quentin Grafton, John Parslow, Tom Kompas, Kathryn Glass, Emily Banks, Kamalini Lokuge
medRxiv 2020.08.31.20185587; doi: https://doi.org/10.1101/2020.08.31.20185587
Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
Citation Tools
Health and Economic Effects of COVID-19 control in Australia: Modelling and quantifying the payoffs of ‘hard’ versus ‘soft’ lockdown
R. Quentin Grafton, John Parslow, Tom Kompas, Kathryn Glass, Emily Banks, Kamalini Lokuge
medRxiv 2020.08.31.20185587; doi: https://doi.org/10.1101/2020.08.31.20185587

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Subject Area

  • Infectious Diseases (except HIV/AIDS)
Subject Areas
All Articles
  • Addiction Medicine (70)
  • Allergy and Immunology (166)
  • Anesthesia (49)
  • Cardiovascular Medicine (447)
  • Dentistry and Oral Medicine (80)
  • Dermatology (55)
  • Emergency Medicine (157)
  • Endocrinology (including Diabetes Mellitus and Metabolic Disease) (188)
  • Epidemiology (5195)
  • Forensic Medicine (3)
  • Gastroenterology (192)
  • Genetic and Genomic Medicine (746)
  • Geriatric Medicine (76)
  • Health Economics (210)
  • Health Informatics (689)
  • Health Policy (350)
  • Health Systems and Quality Improvement (221)
  • Hematology (98)
  • HIV/AIDS (161)
  • Infectious Diseases (except HIV/AIDS) (5787)
  • Intensive Care and Critical Care Medicine (353)
  • Medical Education (101)
  • Medical Ethics (25)
  • Nephrology (80)
  • Neurology (754)
  • Nursing (43)
  • Nutrition (129)
  • Obstetrics and Gynecology (140)
  • Occupational and Environmental Health (230)
  • Oncology (473)
  • Ophthalmology (149)
  • Orthopedics (37)
  • Otolaryngology (93)
  • Pain Medicine (39)
  • Palliative Medicine (19)
  • Pathology (138)
  • Pediatrics (223)
  • Pharmacology and Therapeutics (135)
  • Primary Care Research (96)
  • Psychiatry and Clinical Psychology (851)
  • Public and Global Health (1982)
  • Radiology and Imaging (340)
  • Rehabilitation Medicine and Physical Therapy (154)
  • Respiratory Medicine (282)
  • Rheumatology (93)
  • Sexual and Reproductive Health (72)
  • Sports Medicine (74)
  • Surgery (107)
  • Toxicology (25)
  • Transplantation (29)
  • Urology (39)